Source: BioPortfolio

Euclises: Euclises Pharmaceuticals Inc. Announces CEO Bobby W. Sandage Jr. Ph.D. to Present at 9th Annual Biotech Showcase on January 9 2017

ST. LOUIS&8211;BUSINESS WIRE&8211;Euclises Pharmaceuticals Inc. a privately held drug discovery and development company focused on novel thirdgeneration cyclooxygenase2 COX2 inhibitors for use in the treatment of cancer today announced that Bobby W...

Read full article »
Euclises's Competitors | Euclises's News | Euclises's Financials
Stay up-to-date with the latest news on Euclises
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Bobby W. Sandage's photo - President & CEO of Euclises

President & CEO

Bobby W. Sandage

CEO Approval Rating

79/100

Read more
Stay up-to-date with the latest news on Euclises